The data revealed an upregulation in the expression of CD107a, which is a marker indicative of NK cells activation, within the NK+CML co-culture system, thereby contributing to a reduction in the CML survival rate. This evidence concerns the gene LAMP1 and chronic myelogenous leukemia, BCR-ABL1 positive.